Bristol-Myers Squibb Company
Antibodies against MICA and/or MICB and uses thereof

Last updated:

Abstract:

The disclosure provides antibodies that specifically bind human MICA/B and methods of use thereof. In some aspects, the disclosure is directed to methods of treating a cancer in a subject, comprising administering to the subject an anti-MICA/B antibody.

Status:
Grant
Type:

Utility

Filling date:

22 Mar 2019

Issue date:

8 Feb 2022